Article
Synthesis and biological evaluation of glycogen synthase kinase 3 (GSK-3) inhibitors: an fast and atom efficient access to 1-aryl-3-benzylureas.
Bioorganic & medicinal chemistry letters - 15 Sept 2011
Monte Fabio Lo, Kramer Thomas, Boländer Alexander, Plotkin Batya, Eldar-Finkelman Hagit, Fuertes Ana, Dominguez Juan, Schmidt Boris
Abstract excerpt
The glycogen synthase kinase 3 (GSK-3) is implicated in multiple cellular processes and has been linked to the pathogenesis of Alzheimer's disease (AD). In the course of our research topic we synthesized a library of potent GSK-3 inhibitors. We utilized the urea scaffold present in the potent and highly selective GSK-3 inhibitor AR-A014418 (AstraZeneca). This moiety suits both (a) a convergent approach utilizing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.